[HTML][HTML] TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity

P Riquelme, J Haarer, A Kammler, L Walter… - Nature …, 2018 - nature.com
P Riquelme, J Haarer, A Kammler, L Walter, S Tomiuk, N Ahrens, AK Wege, I Goecze…
Nature communications, 2018nature.com
Human regulatory macrophages (Mreg) have shown early clinical promise as a cell-based
adjunct immunosuppressive therapy in solid organ transplantation. It is hypothesised that
recipient CD4+ T cell responses are actively regulated through direct allorecognition of
donor-derived Mregs. Here we show that human Mregs convert allogeneic CD4+ T cells to
IL-10-producing, TIGIT+ FoxP3+-induced regulatory T cells that non-specifically suppress
bystander T cells and inhibit dendritic cell maturation. Differentiation of Mreg-induced Tregs …
Abstract
Human regulatory macrophages (Mreg) have shown early clinical promise as a cell-based adjunct immunosuppressive therapy in solid organ transplantation. It is hypothesised that recipient CD4+ T cell responses are actively regulated through direct allorecognition of donor-derived Mregs. Here we show that human Mregs convert allogeneic CD4+ T cells to IL-10-producing, TIGIT+ FoxP3+-induced regulatory T cells that non-specifically suppress bystander T cells and inhibit dendritic cell maturation. Differentiation of Mreg-induced Tregs relies on multiple non-redundant mechanisms that are not exclusive to interaction of Mregs and T cells, including signals mediated by indoleamine 2,3-dioxygenase, TGF-β, retinoic acid, Notch and progestagen-associated endometrial protein. Preoperative administration of donor-derived Mregs to living-donor kidney transplant recipients results in an acute increase in circulating TIGIT+ Tregs. These results suggest a feed-forward mechanism by which Mreg treatment promotes allograft acceptance through rapid induction of direct-pathway Tregs.
nature.com